白求恩医学杂志
白求恩醫學雜誌
백구은의학잡지
Journal of Bethune Military Medical College
2014年
4期
334-335
,共2页
阿托伐他汀钙片%血脂康片%冠心病%高脂血症
阿託伐他汀鈣片%血脂康片%冠心病%高脂血癥
아탁벌타정개편%혈지강편%관심병%고지혈증
Atorvastatin%Xuezhikang%Coronary heart disease ( CHD)%Hyperlipidemia
目的:分析比较阿托伐他汀钙片和血脂康片治疗冠心病合并高脂血症的临床效果。方法选取66例冠心病合并高脂血症患者为研究对象,随机分为两组,各33例。观察组患者给予阿托伐他汀钙片治疗,对照组患者给予血脂康片治疗。结果两组患者治疗前血脂各项指标差异均无统计学意义;治疗后两组甘油三酯(TG)均无明显变化( P >0.05);治疗后两组总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)均较治疗前降低( P <0.05),两组高密度脂蛋白胆固醇(HDL-C)均较治疗前升高( P <0.05);治疗后观察组TC、LDL-C和HDL-C指标变化均优于对照组( P <0.05或P <0.01)。结论阿托伐他汀钙片治疗冠心病合并高脂血症的疗效确切,能够使TC和LDL-C下降,HDL-C升高,值得临床推广应用。
目的:分析比較阿託伐他汀鈣片和血脂康片治療冠心病閤併高脂血癥的臨床效果。方法選取66例冠心病閤併高脂血癥患者為研究對象,隨機分為兩組,各33例。觀察組患者給予阿託伐他汀鈣片治療,對照組患者給予血脂康片治療。結果兩組患者治療前血脂各項指標差異均無統計學意義;治療後兩組甘油三酯(TG)均無明顯變化( P >0.05);治療後兩組總膽固醇(TC)和低密度脂蛋白膽固醇(LDL-C)均較治療前降低( P <0.05),兩組高密度脂蛋白膽固醇(HDL-C)均較治療前升高( P <0.05);治療後觀察組TC、LDL-C和HDL-C指標變化均優于對照組( P <0.05或P <0.01)。結論阿託伐他汀鈣片治療冠心病閤併高脂血癥的療效確切,能夠使TC和LDL-C下降,HDL-C升高,值得臨床推廣應用。
목적:분석비교아탁벌타정개편화혈지강편치료관심병합병고지혈증적림상효과。방법선취66례관심병합병고지혈증환자위연구대상,수궤분위량조,각33례。관찰조환자급여아탁벌타정개편치료,대조조환자급여혈지강편치료。결과량조환자치료전혈지각항지표차이균무통계학의의;치료후량조감유삼지(TG)균무명현변화( P >0.05);치료후량조총담고순(TC)화저밀도지단백담고순(LDL-C)균교치료전강저( P <0.05),량조고밀도지단백담고순(HDL-C)균교치료전승고( P <0.05);치료후관찰조TC、LDL-C화HDL-C지표변화균우우대조조( P <0.05혹P <0.01)。결론아탁벌타정개편치료관심병합병고지혈증적료효학절,능구사TC화LDL-C하강,HDL-C승고,치득림상추엄응용。
Objective To compare the curative effect of atorvastatin and Xuezhikang in the treatment of coronary heart disease ( CHD) combined with hyperlipidemia .Methods Sixty-six patients with CHD combined with hyperlipidemia were selected and were randomly divided into experimental group ( n =33) and control group( n =33).The experimental group was given atorvastatin ,and the control group was given Xuezhikang .Results The indexes of blood lipid of the two groups before treatment showed no significant difference and TG of the two groups had no significant change after treatment ( P >0.05), but TC and LDL-C were significantly re-duced( P <0.05),and HDL-C of the two groups were significantly increased ( P <0.05).All the indexes of TC, LDL-C and HDL-C of observation group were better than that of the control group ( P <0.05or P <0.01).Conclution Atorvastatin in the treatment of CHD combined with hyperlipidemia has obvious curative effect and can reduce low density lipoprotein cholesterol and serum total cho -lesterol.